E0 ConsensusPreliminaryPEM unclearSystematic-ReviewPeer-reviewedReviewed
Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
Wong, Timothy L, Weitzer, Danielle J · Medicina (Kaunas, Lithuania) · 2021 · DOI
Quick Summary
Researchers reviewed 21 studies about Long COVID (symptoms lasting months after COVID-19 infection) and compared them to ME/CFS symptoms. They found that Long COVID patients reported 25 out of 29 known ME/CFS symptoms, suggesting these two conditions share many similarities. The study highlights the need for better monitoring and treatment of patients with Long COVID, and calls for more standardized research methods to understand both conditions better.
Why It Matters
This comparison is significant because it suggests Long COVID and ME/CFS may share underlying pathophysiological mechanisms or disease processes, potentially allowing insights from decades of ME/CFS research to inform Long COVID management and vice versa. Recognizing these similarities could accelerate diagnosis and treatment development for both patient populations and improve clinical care protocols.
Observed Findings
- Twenty-five out of 29 ME/CFS symptoms were reported in at least one Long COVID study included in the analysis.
- Twenty-one peer-reviewed studies on Long COVID symptomatology were identified and included in the qualitative synthesis.
- Symptom overlap was observed across multiple ME/CFS case definitions when compared to reported Long COVID presentations.
- Research methodologies and outcome measures varied considerably across included Long COVID studies.
Inferred Conclusions
- Early Long COVID research demonstrates substantial symptomatic overlap with ME/CFS clinical presentation.
- Both conditions warrant similar monitoring and treatment approaches until underlying mechanisms are clarified.
- Standardization of research methodologies is necessary to improve future comparisons and identify genuine similarities versus methodological artifacts.
Remaining Questions
- What are the biological mechanisms underlying the symptom overlap between Long COVID and ME/CFS, and do they share common pathophysiology?
- Do Long COVID and ME/CFS respond to the same treatments, or do their similarities mask important clinical differences?
- How do symptom severity, progression patterns, and recovery trajectories compare between the two conditions?
What This Study Does Not Prove
This study does not prove that Long COVID and ME/CFS are the same disease, nor does it establish causation or shared etiology. The high symptom overlap does not explain whether the conditions share the same biological mechanisms, and findings are limited to early Long COVID research with varying methodologies and definitions. Studies after January 2021 may have documented additional or different symptom patterns.
Tags
Method Flag:PEM_UNCLEARPEM Not DefinedWeak Case DefinitionExploratory Only
Symptom:Post-Exertional MalaiseCognitive DysfunctionUnrefreshing SleepOrthostatic IntolerancePainFatigueSensory SensitivityTemperature Dysregulation
Phenotype:Infection-TriggeredLong COVID Overlap
Metadata
- DOI
- 10.3390/medicina57050418
- PMID
- 33925784
- Review status
- Editor reviewed
- Evidence level
- Higher-level evidence type — systematic reviews, meta-analyses, guidelines, or major syntheses (study type, not a quality guarantee)
- Last updated
- 7 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.